NG
IBB icon

NWK Group’s iShares Biotechnology ETF IBB Stock Holding History

NWK Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-240
Closed -$39K – 85
2021
Q3 		$39K Hold
240
– – 0.02% 71
2021
Q2 		$39K Hold
240
– – 0.02% 80
2021
Q1 		$36K Hold
240
– – 0.02% 121
2020
Q4 		$36K Hold
240
– – 0.02% 117
2020
Q3 		$32K Hold
240
– – 0.02% 114
2020
Q2 		$33K Hold
240
– – 0.02% 113
2020
Q1 		$26K Hold
240
– – 0.02% 109
2019
Q4 		$29K Buy
+240
New +$26.8K 0.02% 129

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

NWK Group's IBB Position: Q4 2021 in Review

NWK Group sold out of iShares Biotechnology ETF (IBB) in Q4 2021, closing a stake of 240 shares — an estimated $39K sold.

NWK Group first reported a position in IBB in Q4 2019 and held it in 8 quarters. The position peaked at $39K in Q3 2021. 962 funds tracked by Wall St. Rank hold IBB as of Q4 2021.

  • NWK Group reported no remaining iShares Biotechnology ETF position as of Q4 2021 after selling out during the quarter.
  • NWK Group sold 240 iShares Biotechnology ETF shares in Q4 2021, an estimated $39K.
  • NWK Group first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 8 quarters.
  • NWK Group's iShares Biotechnology ETF position peaked at $39K in Q3 2021.
  • 962 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2021.

Based on NWK Group's 13F filing for Q4 2021, filed 14 Feb 2022.